Outcomes following the use of angiotensin II in patients with postoperative vasoplegic syndrome: A case series

Outcomes following the use of angiotensin II in patients with postoperative vasoplegic syndrome: A case series

Catecholamine-resistant postoperative vasoplegic syndrome (PVS) lacks effective treatment modalities. Synthetic angiotensin II was recently approved for the treatment of vasodilatory shock; however, its use in PVS is not well described. We report outcomes in six patients receiving angiotensin II for...

Full description

Bibliographic Details
Main Authors: Enfield, K.B (Author), Hulse, M.C (Author), Konkol, S.B (Author), Mihalek, A.D (Author), Morrisette, M.J (Author)
Format: Article
Language:English
Published: NLM (Medline) 2022
Subjects:
Angiotensin II
cardiac vasoplegia
case report
postoperative vasoplegic syndrome
shock
Online Access:View Fulltext in Publisher
Description
Summary:Catecholamine-resistant postoperative vasoplegic syndrome (PVS) lacks effective treatment modalities. Synthetic angiotensin II was recently approved for the treatment of vasodilatory shock; however, its use in PVS is not well described. We report outcomes in six patients receiving angiotensin II for the treatment of isolated PVS. All patients achieved their MAP goal and the majority showed improvement in lactate and background catecholamine dose; however, variables of perfusion changed discordantly. Three of six patients survived to hospital discharge.
ISBN:09745181 (ISSN)
DOI:10.4103/aca.aca_98_21

Similar Items